TRIM4 modulates the ubiquitin-mediated degradation of hnRNPDL and weakens sensitivity to CDK4/6 inhibitor in ovarian cancer

Frontiers of Medicine · Published 2024-12-07 · DOI 10.1007/s11684-024-1103-5

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s11684-024-1103-5

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2024

Related articles